Cysteamine with delayed release (Procysbi®)

Zorginstituut Nederland carried out an assessment of the medicine cysteamine with delayed release (Procysbi®) whereby they reached the following conclusion.
Based on the criteria of the Medicines Reimbursement System (GVS), cysteamine with delayed release is interchangeable with a product that is included in the GVS.